GLOBAL BIOBUSINESS FRONTIER
GLOBAL BIOBUSINESS FRONTIER
Global market development & securing sustainable growth engine
At present, promoting business with 37 firms in 21 countries around the world
Pursue innovative new drugs development & sustainable growth
with early stage revenue stream
Mid-to-long-term sales U$ 3.5 b,
Operating profit U$ 1.7 b achieved in 2030!